Cholesterol homeostasis and cardiovascular risk;Cholesterinhomöostaseund kardiovaskuläres Risiko

Deutsche Medizinische Wochenschrift

Volumn 136, Issue , 2011, Pages 34-38

  Weingartner O ^a   Lutjohann D ^b   Bohm M ^a   Laufs, U ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

cardiovascular risk; cholesterol homeostasis; lathosterol; phytosterols

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL;

ABSORPTION; CARDIOVASCULAR RISK; CHOLESTEROL SYNTHESIS; HOMEOSTASIS; PROSPECTIVE STUDY; REVIEW;

CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; LIVER; REFERENCE VALUES; RISK ASSESSMENT;

EID: 78650660198     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1269438     Document Type: Article

References (52)

1. Al-Jarallah A, Trigatti BL. A role for the scavenger receptor, Class B Type I in high density lipoprotein dependent activation of cellular signaling pathways. Biochim Biophys Acta 2010
2. Assmann G, Cullen P, Erbey J et al. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men. Nutr Metab Cardiovasc Dis 2006; 16: 13-21
3. Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278
4. Berneis K, Rizzo M, Berthold HK et al. Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men. Eur Heart J 2010; 31: 1633-1639
5. Buchwald H, Varco RL, Matts JP et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med 1990; 323: 946-955
6. Calpe-Berdiel L, Escola-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis 2009; 203: 18-31
7. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984; 76: 4-12
8. Davidson MH, Dillon MA, Gordon B et al. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999; 159: 1893-1900
9. Dujovne CA, Ettinger MP, McNeer JF et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 2002; 90: 1092-1097
10. Endo A. A gift from nature: the birth of the statins. Nat Med 2008; 14: 1050-1052
11. Farnier M, Averna M, Missault L et al. Lipid-altering efficacy of ezetimibe/ simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy-The IN-CROSS study. Int J Clin Pract 2009; 63: 547-559
12. Fassbender K, Lutjohann D, Dik MG et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-the LASA study. Atherosclerosis 2008; 196: 283-288
13. Goldstein MR, Mascitelli L, Pezzetta F. Point: Statins, plant sterol absorption, and increased coronary risk. J Clin Lipidol 2008; 2: 306-308
14. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-732
15. Gylling H, Miettinen TA. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients. Atherosclerosis 2002; 160: 477-481
16. Hendriks HF, Weststrate JA, van Vliet T, Meijer GW. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1999; 53: 319-327
17. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78: 965-978
18. Matthan NR, Pencina M, Larocque JM et al. Alterations in cholesterol absorption and synthesis characterize Framingham offspring study participants with coronary heart disease. J Lipid Res 2009: 1527-1535
19. Matthan NR, Resteghini N, Robertson M et al. Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy. J Lipid Res 2010; 51: 202-209
20. McNamara DJ, Davidson NO, Samuel P, Ahrens Jr EH. Cholesterol absorption in man: effect of administration of clofibrate and/or cholestyramine. J Lipid Res 1980; 21: 1058-1064
21. Miettinen TA. Detection of changes in human cholesterol metabolism. Ann Clin Res 1970; 2: 300-320
22. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 20-31
23. Miettinen TA, Gylling H, Strandberg T, Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. BMJ 1998; 316: 1127-1130
24. Miettinen TA, Strandberg TE, Gylling H. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 2000; 20: 1340-1346
25. Miettinen TA, Gylling H. Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. Am J Cardiol 2005; 96: 40D-6D
26. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995; 333: 1308-1312
27. Natarajan P, Ray KK, Cannon CP. High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol 2010; 55: 1283-1299
28. Pinedo S, Vissers MN, von Bergmann K et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPICNorfolk Population Study. J Lipid Res 2007; 48: 139-144
29. Pöss J, Böhm M, Laufs U. [HDL and CETP in atherogenesis]. Dtsch Med Wochenschr 2010; 135: 188-192
30. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000; 35: 1185-1191
31. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
32. Rinninger F, Greten H. Neu entschlüsselte Mechanismen der Cholesterinhomöostase. Dtsch Arztebl 2005; 102: A 516-519
33. Sarwar R, Neuwirth C, Walji S et al. Efficacy of ezetimibe and future role of refractory hyperlipidaemia in high-risk patients. Br J Cardiol 2008; 15: 205-209
34. Schmitz G, Grandl M. The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis. Arterioscler Thromb Vasc Biol 2009; 29: 1718-1722
35. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307
36. Silbernagel G, Fauler G, Renner W et al. The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J Lipid Res 2009; 50: 334-341
37. Silbernagel G, Fauler G, Hoffmann MM et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause-and cardiovascular mortality. J Lipid Res 2010
38. Sudhop T, von Bergmann K. Sitosterolemia-a rare disease. Are elevated plant sterols an additional risk factor? Z Kardiol 2004; 93: 921-928
39. Thuluva SC, Igel M, Giesa U et al. Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 2005; 43: 305-310
40. Teoh H, Mendelsohn AA, Goodman SG et al. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease. Am J Cardiol 2009; 104: 798-804
41. Teupser D, Baber R, Ceglarek U et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010; 3: 331-339
42. van Himbergen TM, Matthan NR, Resteghini NA et al. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J Lipid Res 2009; 50: 730-739
43. Weingärtner O, Laufs U, Böhm M, Lütjohann D. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. Atherosclerosis 2010; 209: 39-41
44. Weingärtner O, Böhm M, Laufs U. Controversial role of plant sterol esters in the management of hypercholesterolaemia. Eur Heart J 2009; 30: 404-409
45. Weingärtner O, Böhm M, Laufs U. [Plant sterols as dietary supplements for the prevention of cardiovascular diseases]. Dtsch Med Wochenschr 2008; 133: 1201-1204
46. Weingärtner O, Lütjohann D, Ji S et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 2008; 51: 1553-1561
47. Weingärtner O, Weingärtner N, Scheller B et al. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis. Coron Artery Dis 2009; 20: 376-382
48. Weingärtner O, Pinsdorf T, Rogacev KS et al. The relationships of markers of cholesterol homeostasis with carotid intima-media thickness. PLoS ONE 2010; 5 (10): e13467 DOI: 10.1371/journal.pone. 0013467
49. Westrate JA, Meijer GW. Plant sterol-enriched margarines amd reduction of plasma total-and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998; 52: 334-343
50. Zhou L, Choi HY, Li W-P, Xu F, Herz J. LRP1 Controls cPLA2 Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export. PLoS ONE 2009; 4 (8): e6853 DOI:10.1371/journal.pone.0006853
51. Wanner C, Krane V, März W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
52. Fellström BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407